Akebia Therapeutics (AKBA) Prepaid Assets (2013 - 2026)

Akebia Therapeutics (AKBA) has 14 years of Prepaid Assets data on file, last reported at $3.6 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $3.6 million, down 54.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 million (down 54.52% YoY), and the FY2025 annual result was $3.8 million, down 48.49% from the prior year.
• Prepaid Assets retreated to $3.6 million in Q1 2026 per AKBA's latest filing, from $3.8 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $42.1 million in Q2 2022 and troughed at $3.6 million in Q1 2026.
• A 5-year average of $16.5 million and a median of $17.2 million in 2022 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2022 and 2024: Prepaid Assets surged 276.79% in 2022, then sank 69.96% in 2024.
• A 5-year view of Prepaid Assets shows it stood at $17.2 million in 2022, then rose by 17.36% to $20.2 million in 2023, then plunged by 63.83% to $7.3 million in 2024, then sank by 48.49% to $3.8 million in 2025, then slipped by 4.51% to $3.6 million in 2026.
• Business Quant data shows AKBA's Prepaid Assets at $3.6 million in Q1 2026, $3.8 million in Q4 2025, and $7.0 million in Q3 2025.